Statement from ALS Canada regarding dexpramipexole research results

Today Biogen Idec reported results from a Phase 3 trial investigating dexpramipexole (dex) in people with amyotrophic lateral sclerosis (ALS). The company said that the trial failed to show slowing of functional decline or improved survival and failed to demonstrate efficacy. Based on these results, the company is discontinuing development

Read More

9th edition of the Fondation André-Delambre Symposium

 

From left to right : Drs. Steve Perrin, Stanley Appel, Nobel Laureate Stanley Prusiner and Jean-Pierre Julien
Quebec City – The 9th Annual Symposium on ALS Fondation André-Delambre was held on September 20 and 21 at Laval University in Quebec City. The organizers of the Symposium, Jean-Pierre Julien and

Read More

6th Edition of Ride for ALS

[French only] Montréal, le 11 septembre 2013 – Les médias sont invités au lancement de la 6e édition du Roulez pour la SLA à l’hôtel Sacacomie à Saint-Alexis-des-Monts. Cet événement à vélo unique de trois jours se tiendra du 13 au 15 septembre 2013 en Mauricie. La conférence

Read More

4th Edition of Ride for ALS, City Edition

 
[French only] Venez accueillir les cyclistes à votre hôtel de ville!
Montréal, le 5 septembre 2013 – La Société de la Sclérose latérale amyotrophique du Québec, en collaboration avec la Ville de Boucherville, vous convie à la 4e édition du tour cycliste Roulez pour la SLA – Édition en

Read More
What to Do In the Event of Death

What to Do In the Event of Death

The death of a loved one is a difficult time, during which a number of pressing administrative tasks must be accomplished. The What to Do in the Event of Death guide provides an overview of the main obligations you have to fulfill and the applicable deadlines.
Published by Services Québec,

Read More